What do we know about lupus membranous nephropathy? An analytic review

Arthritis Care and Research

Volumn 47, Issue 4, 2002, Pages 450-455

  Kolasinski, Sharon L ^a,b   Chung, James B ^a   Albert, Daniel A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN;

CLINICAL FEATURE; CREATININE CLEARANCE; HUMAN; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; PLASMAPHERESIS; PROGNOSIS; PROTEINURIA; REVIEW; TREATMENT OUTCOME;

EID: 0037103155     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10417     Document Type: Review

References (51)

1. Renal biopsy in lupus nephritis: What for, when and how often?
2. Lupus nephritis: Clinical course as related to morphologic forms and their transitions
3. Lupus nephritis
4. Prognostic factors in lupus nephritis: Contribution of renal histologic data
5. Kidney biopsy in systemic lupus erythematosus. II. Survival analyses according to biopsy results
6. Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis
7. Therapy of lupus nephritis: Controlled trial of prednisone and cytotoxic drugs
8. The pathogenesis and prognosis of lupus nephritis: Information from repeat renal biopsy
9. Prognostic determinants in lupus nephritis: A long-term clinicopathologic study
10. Pathologic differentiation between lupus and nonlupus membranous glomerulopathy
11. Meta-analysis in clinical trials
12. Clinical outcome of three discrete histologic patterns of injury in severe lupus glomerulonephritis
13. Clinical status of patients after 10 years of lupus nephritis
14. Lupus in the 1980s. III. Influence of clinical variables, biopsy, and treatment on the outcome in 150 patients with lupus nephritis seen at a single center
15. Long-term outcome in systemic lupus erythematosus membranous glomerulonephritis: Lupus Nephritis Collaborative Study Group
16. Lupus membranous nephropathy: Long-term outcome
17. Lupus membranous glomerulonephritis: Different prognostic subgroups obscured by imprecise histologic classifications
18. Sequential use of cyclophosphamide and azathioprine in the treatment of membranous lupus nephropathy (MLN) with nephrotic syndrome
19. Renal involvement in systemic lupus erythematosus: A study of 180 patients from a single center
20. Treatment of membranous nephropathy in systemic lupus erythematosus
21. Kidney biopsy in SLE. I. A clinical-morphologic evaluation
22. Lupus nephritis: Clinical and pathological correlation
23. Cyclosporine treatment of lupus membranous nephropathy
24. Treatment of membranous lupus nephritis
25. Treatment of membranous lupus nephritis
26. Long-term treatment of systemic lupus erythematosus with cyclosporin A
27. Does cyclosporin have a role in the treatment of membranous nephropathy?
28. Lupus nephritis: Prognostic factors and probability of maintaining life-supporting renal function 10 years after diagnosis
29. Systemic lupus with nephritis: A long-term study
30. Glomerulonephritis
31. Prognosis of untreated patients with idiopathic membranous nephropathy
32. Membranous nephropathy: A 19 year prospective study in 51 patients
33. The therapy of idiopathic membranous glomerulonephritis
34. Idiopathic membranous nephropathy: To treat or not to treat?
35. Prognosis of idiopathic membranous nephropathy: A methodologic meta-analysis
36. A controlled study of short-term prednisone treatment in adults with membranous nephropathy
37. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy
38. Treatment of renal failure in idiopathic membranous nephropathy with azathioprine and prednisolone
39. Does immunosuppression with prednisolone and azathioprine alter the progression of idiopathic membranous nephropathy?
40. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy
41. Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency
42. Immunosuppression and outcome in idiopathic membranous nephropathy
43. The treatment of idiopathic membranous nephropathy
44. Treatment of lupus nephritis: A meta-analysis of clinical trials
45. Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trials
46. Treatment of progressive membranous glomerulopathy: A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone
47. Preserving renal function in patients with membranous nephropathy: Daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide
48. Severe bone marrow failure associated with the use of alternating steroid with chlorambucil in lupus membranous nephropathy in Chinese
49. Use of mycophenolate mofetil in resistant membranous nephropathy
50. Mycophenolate mofetil in lupus nephritis